DNLI
#1632
Denali Therapeutics Inc. - Common Stock
19.4 5 USD
+0.04%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+4.18%
Variación mensual
-7.78%
Variación en los últimos 6 meses
+1.14%
Cambio anual
+20.28%
Cierres anteriores
18.6 7
Open
18.4 7
Mínimo
18.4 6
Máximo
19.5 2
Financials
- Market Capitalization 3.11 B
- Employee 507
- Founded 2013
- CEO N/A
- Website www.denalitherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG008P7F869
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-5.56
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1624 |  AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 28.14 USD | +3.46% | +0.79% | -11.62% | +97.61% | 3.14 B USD | ||
| 1631 |  RCUS Arcus Biosciences, Inc. Common Stock | 24.42 USD | +2.52% | -0.20% | -1.05% | +54.56% | 3.11 B USD | ||
| 1634 |  DYN Dyne Therapeutics, Inc. - Common Stock | 16.64 USD | +1.65% | +8.69% | -9.57% | -28.92% | 3.11 B USD | ||
| 1668 |  ELVN Enliven Therapeutics, Inc. - Common Stock | 40.98 USD | +0.86% | -12.70% | -25.49% | +98.35% | 3.00 B USD |